Skip to main content

Exane Derivatives

SEC CIK
0001623883
Latest filing
Jul 12, 2022

PLRX holding history

Pliant Therapeutics, Inc. in every 13F filed by Exane Derivatives, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PLRX overviewAll 13F holders of PLRXFull Q2 2022 holdings

Shares (Q2 2022)
234
Value
$1.87K
% of portfolio
<0.1%
Quarters held
4
Since Q3 2021
Holdings of PLRX by Exane Derivatives, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2022234$1.87K<0.1%−5,056−95.6%ReducedHolders
Q1 20225,290$37.1K<0.1%+2,319+78.1%AddedHolders
Q4 20212,971$00.0%00.0%UnchangedHolders
Q3 20212,971$48.9K<0.1%+2,971NewHolders